Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group (Q36641763)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2000

Language	Label	Description	Also known as
English	Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group	scientific article published on May 2000

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Skinner R

1

1 reference

Europe PubMed Central

15 August 2017

Cotterill SJ

2

1 reference

Europe PubMed Central

15 August 2017

Stevens MC

3

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

82

1 reference

Europe PubMed Central

15 August 2017

10

1 reference

Europe PubMed Central

15 August 2017

1636-1645

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1214

0 references

The long-term survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Risk factors for ifosfamide nephrotoxicity in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide, mesna, and nephrotoxicity in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide nephrotoxicity in paediatric cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Albumin Excretion as a Measure of Glomerular Dysfunction in Children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide in refractory male germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Toxicity of high-dose ifosfamide in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Nephrotoxicity after ifosfamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Assessment of chemotherapy-associated nephrotoxicity in children with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Acute ifosfamide-induced proximal tubular toxic reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide in paediatric oncology: tried but not tested?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Ifosfamide, Fanconi's syndrome, and rickets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Reversible hypophosphatemic rickets following ifosfamide treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Iphosphamide-induced nephrotoxicity in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

30 September 2017

Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Progressive glomerular toxicity of ifosfamide in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Nephrotoxicity associated with ifosfamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Simplified quantification of urinary protein excretion in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Fanconi syndrome after ifosfamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Acute ifosfamide-induced tubular toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Ifosfamide in pediatric malignant solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

The impact of childhood cancer on the United States and the world

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

28 June 2018

Renal function abnormalities after ifosfamide treatment in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374517

20 September 2018

Clinical trial of isophosphamide (NSC-109724)--results and side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE GROWTH AND MATURATION OF HUMAN GLOMERULI AND PROXIMAL CONVOLUTIONS FROM TERM TO ADULTHOOD: STUDIES BY MICRODISSECTION

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal function in children and adolescents following 72 g/m2 of ifosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postnatal development of tubular phosphate reabsorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and safety of high-dose ifosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose ifosfamide alone and in combination for solid malignancies in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10817497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2000.1214

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36641763&oldid=1642897018"